Outstanding
Imaging Damage: Scoring Versus Measuring
Is It Time for Rheumatologists to Rethink the Use of Manual Therapies?
OMERACT 6 Brings New Perspectives to Rheumatology Measurement Research
Osteoprotegerin, RANK, and RANK Ligand: The Good, the Bad, and the Ugly in Rheumatoid Arthritis
Editorial
Imaging Damage: Scoring Versus Measuring
In Quest of the Holy Grail: Efficacy versus Effectiveness in Rheumatoid Arthritis
Infections in RA — A New Phenomenon?
Infliximab: Additional Safety Data from an Open Label Study
Is It Time for Rheumatologists to Rethink the Use of Manual Therapies?
Leisure Time Physical Activity and Well-Being: Learning from People Living with Arthritis
Macrophage Activation Syndrome — What's in a Name!
Managing Comorbidities in the Rheumatic Diseases: The New Reality
Measuring Disease Activity in Systemic Lupus: Progress and Problems
Methotrexate: Vital New Information About a Middle Aged Drug
Monitoring MTX Hepatic Toxicity in RA: Is It Time to Update the Guidelines?
Novel Concepts of Severity Mechanisms in Ankylosing Spondylitis
NSAID Toxicity: Where Are We and How Do We Go Forward?
OA and BMD: What Is the Relation and Why Does It Matter?
OMERACT 6 Brings New Perspectives to Rheumatology Measurement Research
Opioid Therapy for Osteoarthritis of the Hip and Knee: Use It or Lose It?
Options in Disability Determination. Lessons That Pertain to the Regional Musculoskeletal Disorders
Osteoarthritis: Simple Analgesics versus NSAID
Osteoprotegerin, RANK, and RANK Ligand: The Good, the Bad, and the Ugly in Rheumatoid Arthritis
Pain Is Real; Fibromyalgia Isn't
Patient Self-Management in Arthritis? Yes!
Patient Self-Management in Arthritis? Yes, More Research!
